TTK Healthcare Limited

TTKHLTCARE

INE910C01018

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:53 14/06/2024 BST			5-day change	1st Jan Change
1,469 ^INR	-0.81%		+1.07%	+4.23%

05-24	TTK Healthcare Names CEO	MT
05-24	TTK Healthcare Limited Announces Management Changes, Effective June 1, 2024	CI

TTK Healthcare Limited Announces Executive Changes with Effect from 1 June, 2024

May 24, 2024 at 10:13 am

TTK Healthcare Limited at its board meeting held on May 24, 2024, approved the relinquishment of office of Chief Executive Officer (CEO) by Mr. T T Raghunathan, with effect from 1st June, 2024. He would continue to hold the position of Executive Chairman (Wholetime Director) in the Company and S Kalyanaraman has been appointed as Chief Executive Officer (CEO), with effect from 1st June, 2024.

Latest news about TTK Healthcare Limited

TTK Healthcare Names CEO	05-24	MT
TTK Healthcare Limited Announces Management Changes, Effective June 1, 2024	05-24	CI
TTK Healthcare Limited Announces Executive Changes with Effect from 1 June, 2024	05-24	CI
TTK Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-24	CI
TTK Healthcare Limited Recommends Dividend for the Financial Year Ended 31 March, 2024	05-24	CI
TTK Healthcare Resumes Production at Foods Division Factory in Jaipur, India	05-08	MT
TTK Healthcare Sees Production Disruption at Foods Division Factory in Jaipur, India	05-01	MT
TTK Healthcare Limited Appoints S Kalyanaraman as Chief Executive Officer, Effective 1 June, 2024	02-02	CI
TTK Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-02	CI
TTK Healthcare's Production at Chennai, Unit Disrupted Due to Floods	12-06	MT
TTK Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-03	CI
TTK Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-03	CI
TTK Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	01/08/23	CI
TT Krishnamachari & Co., Ltd., T T Jagannathan, and T T Raghunathan cancelled the acquisition of remaining 26.888% shares in TTK Healthcare Limited.	27/07/23	CI
TTK Healthcare Revises Floor Price for Delisting	14/07/23	MT
India's Mankind Pharma posts 43% jump in Q4 profit in first results since listing	30/05/23	RE
TTK Healthcare Logs Higher Net Profit in Fiscal Q4	24/05/23	MT
TTK Healthcare Limited Proposes Dividend for the Financial Year Ended 31St March, 2023	23/05/23	CI
TTK Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23/05/23	CI
TT Krishnamachari & Co., Ltd., T T Jagannathan, and T T Raghunathan, made an offer to acquire remaining 26.888% shares in TTK Healthcare Limited.	04/04/23	CI
TTK Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	07/02/23	CI
TTK Healthcare Posts Decline in Fiscal Q2 Consolidated Net Profit	28/10/22	MT
India's TTK Healthcare Q2 profit more than doubles on higher sales of medical devices	28/10/22	RE
TTK Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	28/10/22	CI
TTK Healthcare Appoints New Chairman	09/09/22	MT

Chart TTK Healthcare Limited

Duration

Period

More charts

Company Profile

TTK Healthcare Limited is an India-based company, which provides consumer and healthcare products. The Company's segments include Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods and Others. The Animal Welfare segment comprises products for veterinary use. The Consumer Products segment comprises marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, good home range of scrubbers, air fresheners and various others. Its brands also include Skore and HUG n WAG. The Medical Devices segment includes artificial heart valves, orthopedic implants and others. The Protective Devices segment comprises manufacturing and marketing of male contraceptives and other allied products. The Foods segment comprises manufacturing and marketing of food products. Under the brand name Fryums, extruded products such as papads are offered to its business to business and export customers. The Others segment includes printing and publishing of maps and atlases.

Sector

Pharmaceuticals

Calendar

23/07/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
TTK HEALTHCARE LIMITED	+4.23%	248M
MCKESSON CORPORATION	+27.42%	76.68B
CARDINAL HEALTH, INC.	-0.60%	24.41B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+10.46%	8.48B
HUADONG MEDICINE CO., LTD	-25.33%	7.47B
H. LUNDBECK A/S	+13.86%	5.21B
GALENICA AG	+0.07%	4.12B
EBOS GROUP LIMITED	-8.45%	3.86B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-3.20%	3.56B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+14.22%	3.4B

Pharmaceuticals Wholesale